|Articles|June 20, 2023
End-to-End Oligonucleotide Solutions
Author(s)Agilent
This short video provides an overview of a complete, end-to-end oligonucleotide workflow solutions
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
